Willem Bram de Rijk - Concepedia

Author

Willem Bram de Rijk

Also Known As

W Bram de Rijk, W. B. De Rijk, W. B. de Rijk, W.B. De Rijk, Willem Bram De Rijk, Willem Bram De Rijk, Willem Bram de Rijk

Publications

696

Citations

H-Index

Concepts

All Affiliations

Instituut voor Tropische Geneeskunde University of Antwerp International Union Against Tuberculosis and Lung Disease Aidjan-Lagos Corridor Organization Damien Foundation

About

Willem Bram de Rijk is an author at Instituut voor Tropische Geneeskunde specializing in health sciences, molecular diagnostics, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	443
2	Medicine	2	2	443
3	Microbiology	1	1	203
4	Molecular Biology	1	1	203
5	Pathology	1	1	240

Willem Bram de Rijk

Publications

665

Citations

H-Index

Page 1

	Year	Citations
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard Armand Van Deun, K. J. M. Aung, Valentin Bola, Journal of Clinical Microbiology Tuberculosis PreventionInsufficient SpecificityPathologyPharmacotherapyAntibiotic Resistance	2013	240
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific <i>rpoB</i> Mutations Leen Rigouts, Mourad Gumusboga, Willem Bram de Rijk, Journal of Clinical Microbiology Molecular BiologyAntibiotic ResistanceDrug ResistanceRmp ResistanceMedical Microbiology	2013	203
Specific<i>gyrA</i>gene mutations predict poor treatment outcome in MDR-TB Leen Rigouts, Nele Coeck, Mourad Gumusboga, Journal of Antimicrobial Chemotherapy	2015	95
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda Jean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, The Lancet Microbe	2020	61
Multicenter External Quality Assessment Program for PCR Detection of Mycobacterium ulcerans in Clinical and Environmental Specimens Miriam Eddyani, Caroline J. Lavender, Willem Bram de Rijk, PLoS ONE	2014	32
High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. Levan Jugheli, Leen Rigouts, Isdore Chola Shamputa, PubMed	2008	20
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide Jean Claude Semuto Ngabonziza, Awa Ba-Diallo, Elisa Tagliani, PLoS ONE	2017	14

Page 1